Javascript must be enabled for this website to work.

#script { display:none; } #noScript{ width: 350px; height: 175px; text-align: center; background: white; padding: 35px; display: block; margin-top: -87px; top: 50%; position: absolute; border-bottom: 1px solid #c2c2c2; border-left: 1px solid #e6e6e6; border-right: 1px solid #e6e6e6; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; margin-left: 50%; left: -175px; } #noScript img{width:100%;} body{background:#f7f7f7;}

PBS broadens access to COPD triple therapy and lung cancer immunotherapy

FOT better than spirometry for identifying poor asthma control

Novel therapy success for ‘untreatable’ P. aeruginosa in CF lung transplant patient

RACP training program gets 79% approval rating from participants

Today’s disease names are less catchy, but also less likely to cause stigma

holy grail

Improving respiratory outcomes for preterm babies

8 May 2017

Professor Jane Pillow

Professor Jane Pillow is co-director of the Centre for Neonatal Research and Education at the University of Western Australia and consultant neonatologist, Women and Newborns Health Service.

Can you describe the aim of your research in 10 words? To improve the immediate and long-term outcomes of premature infants What have you achieved in this area so far? Early research focused on the use of high-frequency oscillatory ventilation (HFOV) and how it can be used safely to protect the immature lung. I have ...

Already a member?

Forgot my password

Not a member yet?

Join now for free, independent news relevant to your specialty. the limbic is intended for practicing health care professionals only.

Title: *

First name: *

Last name: *

Country: *

Email: *

Password: *

Password must contain at least 8 characters including 1 letter and 1 number.

AHPRA Number: * Find my AHPRA number

What's your primary area of interest? *

The limbic's weekly newsletter is a round up of key news highlights that's relevant to your specialty. The newsletter may contain advertising and educational or promotional material from carefully selected industry partners including pharmaceutical companies, government and not-for-profit organisations.

You will not receive advertisers only emails and your details will not be shared with any other party.

I would like to receive the limbic newsletter *

I have read and agree to the limbic Terms and Conditions & Privacy Policy *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Top Stories